Francesco Cicone
Francesco Cicone is an expert in Nuclear medicine at Azienda Ospedaliero Universitario Mater Domini (Italy). Francesco Cicone has authored 91 publications, the most recent in 2026. SLR score: 269 (community average: 125). How the SLR is computed.
LeadR Profile
Nuclear medicine
Subspecialties: Oncology - Cardiology - Endocrinology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2008 - 2026
Number : 91
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| [ 18F]FDG PET during immunotherapy: mind the gap between evidence, imaging guidelines, and oncology practice. PMID 42463966 — tomography, neoplasms, carcinoma, non-small-cell lung, immunotherapy, fluorodeoxyglucose f18, therapeutics | Eur J Nucl Med Mol Imaging | 2026 | 0 |
| Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0. PMID 39762634 — positron-emission tomography, brain, neoplasm metastasis, nuclear medicine | Eur J Nucl Med Mol Imaging | 2025 | 2 |
| Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors. PMID 40064181 — somatostatin, neoplasms, neurosecretory systems, hormones, neuroendocrine tumors, receptors, somatostatin, therapeutics, nervous system, receptors, peptide | J Neuroendocrinol | 2025 | 0 |
| Pediatric Huntington Disease Brains Have Distinct Morphologic and Metabolic Traits: the RAREST-JHD Study. PMID 39367695 — brain, huntington disease | Mov Disord Clin Pract | 2024 | 1 |
| Do we need dosimetry for the optimization of theranostics in CNS tumors? PMID 39351795 — brain neoplasms, neoplasms, radiopharmaceuticals, therapeutics | Neuro Oncol | 2024 | 3 |
LeadR Networks
Main global connection map